Ausgabe 1/2017
Inhalt (9 Artikel)
Hypomethylating Agents as a Therapy for AML
Claude Gardin, Hervé Dombret
The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
Benjamin L. Lampson, Matthew S. Davids
Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)
Erin M. Pettijohn, Shuo Ma
A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia
Mazie Tsang, Sameer A. Parikh
10 Years of Preparedness by the Radiation Injury Treatment Network
Cullen Case Jr.
Immune Checkpoint Blockade and Hematopoietic Stem Cell Transplant
Reid W. Merryman, Philippe Armand
Clinical Studies in Hematologic Microtransplantation
Kevin A. David, Dennis Cooper, Roger Strair
A View from the Plateau: Is There a Role for Allogeneic Stem Cell Transplantation in the Era of Highly Effective Therapies for Multiple Myeloma?
Damian J. Green, William I. Bensinger
T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders
Alice Bertaina, Angela Pitisci, Matilde Sinibaldi, Mattia Algeri